Toward internal threshold for toxicological concern: in vitro hepatocyte metabolism testing of 207 chemicals using cryopreserved suspended hepatocytes for physiologically based pharmacokinetic modeling
Toxicological Sciences · 01.08.2026 · 209 (8)
DOI: 10.1093/toxsci/kfag086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 03.08.2026. Verfasst von Corie A Ellison und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Procter and Gamble Company, Mason, OH 45040, United States. Hauptthemen laut MEDLINE: Hepatocytes, Dose-Response Relationship, Drug, Cryopreservation. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ACC LRI and RIFM.
Abstract (Originalsprache)
In vitro hepatic metabolic clearance data were generated for a diverse set of 207 chemicals to advance the collaborative initiative to establish an internal Threshold of Toxicological Concern (iTTC). The data reported herein are being used for chemical-specific physiologically based pharmacokinetic (PBPK) modeling to convert oral No Observable Adverse Effect Levels (NOAELs) into estimates of internal exposure. Hepatocyte assays were conducted at 2 concentrations (0.1 and 1 µM) using cryopreserved cells from multiple species, ensuring applicability to existing mammalian toxicity studies. The metabolic clearance measurements across chemicals varied significantly, ranging from 0 to 4,294 µl/min/106 cells at 0.1 µM and from 0 to 2,351 µl/min/106 cells at 1 µM. A substantial proportion of the chemicals (68% at 0.1 µM and 62% at 1 µM) exhibited clearance values below 30 µl/min/106 cells. Additionally, we observed a strong correlation (R = 0.8) between intrinsic clearance (CLint) values determined at the 2 concentrations. These data contribute to establishing robust iTTC values that can be utilized for: (i) extrapolating from an oral in vivo study to dermal and inhalation exposures, (ii) risk-based screening of aggregate exposures of a given substance from multiple routes of exposures, and (iii) risk-based screening of human biomonitoring results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Procter and Gamble Company, Mason, OH 45040, United States.
- Research Institute for Fragrance Materials, Woodcliff Lake, NJ 07677, United States.
- American Chemistry Council, Washington, DC 20002, United States.
- Discovery Sciences, RTI International, Durham, NC 27709, United States.
ORCID-Profile: Corie A Ellison, Anne Marie Api
Förderung
- ACC LRI and RIFM
Zitieren
APA
Ellison, C. A., Api, A. M., Becker, R. A., Black, S., Joshi, K., & Selechnik, D. (2026). Toward internal threshold for toxicological concern: in vitro hepatocyte metabolism testing of 207 chemicals using cryopreserved suspended hepatocytes for physiologically based pharmacokinetic modeling. Toxicological Sciences, 209(8). https://doi.org/10.1093/toxsci/kfag086
Vancouver
Ellison CA, Api AM, Becker RA, Black S, Joshi K, Selechnik D. Toward internal threshold for toxicological concern: in vitro hepatocyte metabolism testing of 207 chemicals using cryopreserved suspended hepatocytes for physiologically based pharmacokinetic modeling. Toxicological Sciences. 2026;209(8). doi:10.1093/toxsci/kfag086
BibTeX
@article{Ellison2026,
author = {Ellison, Corie A and Api, Anne Marie and Becker, Richard A and Black, Sherry and Joshi, Kaushal and Selechnik, Dan},
title = {Toward internal threshold for toxicological concern: in vitro hepatocyte metabolism testing of 207 chemicals using cryopreserved suspended hepatocytes for physiologically based pharmacokinetic modeling},
journal = {Toxicological Sciences},
year = {2026},
volume = {209},
number = {8},
doi = {10.1093/toxsci/kfag086}
}
EUVIMED